Annovis Bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Annovis Bio generated cash of -$39,967,304, which is less than the previous year. Cash used in financing activities reached the amount of $17,344,331 last year. Net change in cash is therefore -$22,622,973.
Cash Flow
| 2017 | -537.48K | 0 | 332.49K |
|---|---|---|---|
| 2018 | -558.60K | 0 | 246.44K |
| 2019 | -476.54K | 0 | 443.08K |
| 2020 | -3.97M | 0 | 12.04M |
| 2021 | -9.13M | 0 | 46.74M |
| 2022 | -17.31M | 0 | 4.61K |
| 2023 | -39.96M | 0 | 17.34M |
ANVS Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 28.37M | 45.68M | 8.07M | 1.85K | 35.31K | 347.47K | 552.45K |
Operating activities | |||||||
Net income | -56.20M | -25.32M | -14.48M | -5.46M | -990.98K | -713.87K | -682.34K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 0 | 0 | 0 | 129K | 1.19M | 0 | 0 |
Stock-based compensation expense | 4.62M | 9.15M | 4.69M | 1.86M | 8.48K | 0 | 48.49K |
| Deferred income tax benefit | 4.62M | 9.15M | 4.69M | 1.86M | 8.48K | 0 | 48.49K |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 0 | 0 | 0 | 735.07K | -735.07K | 0 | 0 |
Inventories | 0 | 0 | 0 | -735.07K | 735.07K | 0 | 0 |
Accounts payable | 0 | 3.27M | 346.21K | -695.66K | 969.09K | -2.68K | 61.82K |
Cash generated by operating activities | -39.96M | -17.31M | -9.13M | -3.97M | -476.54K | -558.60K | -537.48K |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing activities | |||||||
Common Stock Issued | 16.88M | 4.61K | 46.64M | 12.03M | -78.61K | 2.8K | 8.49K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -12.03M | 530K | 0 | 0 |
Cash used in financing activities | 17.34M | 4.61K | 46.74M | 12.04M | 443.08K | 246.44K | 332.49K |
Net Change In Cash | -22.62M | -17.30M | 37.61M | 8.07M | -33.45K | -312.16K | -204.98K |
Cash at end of period | 5.75M | 28.37M | 45.68M | 8.07M | 1.85K | 35.31K | 347.47K |
| Data source | Data source | Data source | Data source | Data source |